Pavli P - Search Results

1

Two rare cases of Epstein-Barr virus-associated lymphoproliferative disorders in inflammatory bowel disease patients on thiopurines and other immunosuppressive medications.

Subramaniam K, Cherian M, Jain S, Latimer M, Corbett M, D'Rozario J, Pavli P. Subramaniam K, et al. Among authors: pavli p. Intern Med J. 2013 Dec;43(12):1339-42. doi: 10.1111/imj.12287. Intern Med J. 2013. PMID: 24330365

2

Advances in the management of inflammatory bowel disease.

Grimpen F, Pavli P. Grimpen F, et al. Among authors: pavli p. Intern Med J. 2010 Apr;40(4):258-64. doi: 10.1111/j.1445-5994.2010.02163.x. Epub 2010 Jan 4. Intern Med J. 2010. PMID: 20059603 Review.

3

Infliximab-induced autoimmune hepatitis in Crohn's disease treated with budesonide and mycophenolate.

Subramaniam K, Chitturi S, Brown M, Pavli P. Subramaniam K, et al. Among authors: pavli p. Inflamm Bowel Dis. 2011 Nov;17(11):E149-50. doi: 10.1002/ibd.21880. Epub 2011 Aug 30. Inflamm Bowel Dis. 2011. PMID: 21987301 No abstract available.

4

Should patients be screened for hereditary cancer syndromes before starting anti-TNF-α therapy?

Subramaniam K, Tucker K, Craft P, Pavli P. Subramaniam K, et al. Among authors: pavli p. Inflamm Bowel Dis. 2011 Nov;17(11):E151-2. doi: 10.1002/ibd.21883. Epub 2011 Aug 30. Inflamm Bowel Dis. 2011. PMID: 21987302 No abstract available.

5

Foot drop developing during infliximab therapy for inflammatory bowel disease.

Subramaniam K, Hughes A, Pavli P. Subramaniam K, et al. Among authors: pavli p. Inflamm Bowel Dis. 2013 Feb;19(2):E24-5. doi: 10.1002/ibd.22881. Inflamm Bowel Dis. 2013. PMID: 22253031 No abstract available.

6

Risk of non-melanoma skin cancer with thiopurine use in inflammatory bowel disease.

Subramaniam K, Pavli P. Subramaniam K, et al. Among authors: pavli p. J Gastroenterol Hepatol. 2012 Feb;27(2):193-4. doi: 10.1111/j.1440-1746.2011.07030.x. J Gastroenterol Hepatol. 2012. PMID: 22260282 No abstract available.

7

Glatiramer acetate induced hepatotoxicity.

Subramaniam K, Pavli P, Llewellyn H, Chitturi S. Subramaniam K, et al. Among authors: pavli p. Curr Drug Saf. 2012 Apr;7(2):186-8. doi: 10.2174/157488612802715690. Curr Drug Saf. 2012. PMID: 22873505

8

Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: a review.

Subramaniam K, D'Rozario J, Pavli P. Subramaniam K, et al. Among authors: pavli p. J Gastroenterol Hepatol. 2013 Jan;28(1):24-30. doi: 10.1111/jgh.12015. J Gastroenterol Hepatol. 2013. PMID: 23094824 Review.

9

Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.

Subramaniam K, Richardson A, Dodd J, Platten J, Shadbolt B, Pavli P. Subramaniam K, et al. Among authors: pavli p. Intern Med J. 2014 May;44(5):464-70. doi: 10.1111/imj.12397. Intern Med J. 2014. PMID: 24612209

10

Hepatosplenic T-cell lymphoma, immunosuppressive agents and biologicals: what are the risks?

Subramaniam K, Yeung D, Grimpen F, Joseph J, Fay K, Buckland M, Talaulikar D, Elijah J, Clarke AC, Pavli P, Moore J. Subramaniam K, et al. Among authors: pavli p. Intern Med J. 2014 Mar;44(3):287-90. doi: 10.1111/imj.12363. Intern Med J. 2014. PMID: 24621284 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters